Landscapes / Companies
RHEACELL GmbH & Co. KG not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
Drugs
2
in active trials · 5 in all
Trials
3 active
7 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Apr 2027Phase 3 trial completes | |||
| Next date | Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Venous Leg Ulcer | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Epidermolysis Bullosa | ||||
| Open drug page | |||||
About
- No active trial
- allo-APZ2-ACLF, allo-APZ2-EB, LSC2
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021